Novolizer Salbutamol (Salbutamol Sulfate)

Salbutamol sulfate, the active ingredient in Novolizer Salbutamol, is a short‑acting β2‑adrenergic agonist presented as a inhalation powder for oral inhalation use. It provides rapid bronchodilation for relief of bronchospasm in asthma and chronic obstructive pulmonary disease patients. GNH USA supplies Novolizer Salbutamol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Novolizer Salbutamol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Novolizer Salbutamol is a short‑acting β2‑agonist that acts on the bronchial smooth‑muscle pathway to relieve reversible airway obstruction.

- Asthma: rapid relief of acute bronchospasm and prevention of exercise‑induced symptoms. - Chronic obstructive pulmonary disease (COPD): short‑term bronchodilation to improve airflow during exacerbations. - Exercise‑induced bronchoconstriction: prophylactic bronchodilation when administered before physical activity.

Adverse reactions to inhaled salbutamol are generally dose‑related and may vary between individuals.

Common Side Effects: - Tremor: mild shaking of the hands or limbs. - Headache: transient headache episodes. - Palpitations: sensation of rapid or irregular heartbeat. - Throat irritation: mild discomfort or dryness in the throat. - Cough: brief coughing after inhalation. - Nausea: occasional feeling of queasiness.

Serious or Rare Side Effects: - Paradoxical bronchospasm: worsening airway narrowing after inhalation. - Severe tachycardia: markedly increased heart rate requiring medical attention. - Hypokalemia: low blood potassium levels detectable on laboratory testing. - Angio‑edema: swelling of the face, lips or tongue. - Anaphylactic reaction: rare systemic allergic response. - Cardiac arrhythmia: abnormal heart rhythm potentially requiring intervention.

When using Novolizer Salbutamol, consider the following safety measures:

- Assess asthma control: ensure the patient’s baseline asthma is adequately managed before relying on rescue inhaler use. - Monitor cardiovascular status: watch for rapid heart rate or palpitations, especially in patients with known heart disease. - Avoid excessive use: limit rescue inhalations to the prescribed maximum to reduce risk of tolerance and side effects. - Review concomitant medications: check for other β‑agonists or sympathomimetics that may amplify effects. - Store at ambient temperature: keep below 25°C, retain in original packaging, and protect from moisture.

Salbutamol may interact with several drug classes, influencing its safety or efficacy.

Major Interactions (Avoid): - Non‑selective β‑blockers: may diminish bronchodilator response and precipitate bronchospasm. - Diuretics (especially loop diuretics): can exacerbate hypokalemia when combined with salbutamma.

Moderate Interactions (Monitor Closely): - MAO‑inhibitors and tricyclic antidepressants: may increase the risk of cardiovascular side effects. - Theophylline: additive bronchodilator effect may heighten tremor or tachycardia. - High‑dose inhaled corticosteroids: may mask worsening asthma control, delaying needed adjustments. - Beta‑agonist combination inhalers: concurrent use can increase systemic exposure.